Responding NK-cells from SD patients are less activated (CD69) and displayed decreased cytotoxic potential (GzmB, perforin) and decreased expression of activating receptors NKG2D and NKp46, compared to those from non-SD patients (Fig. 6c). The gene discussed is CD69; the disease is Salla disease.